Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal. (2024). Journal of Patan Academy of Health Sciences, 11(1), 21-26. https://doi.org/10.3126/jpahs.v11i1.65652